Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

July 5, 2023

Study Completion Date

January 31, 2024

Conditions
Soft Tissue SarcomaAdult Soft Tissue SarcomaResectable Soft Tissue Sarcoma
Interventions
RADIATION

Neoadjuvant RT

"Dosimetric CT scan with contrast injection for treatment planning. Radiation therapy at a dose of 50Gy in 25 fractions, 5 fractions per week. Daily pre-treatment positioning tomographic imaging (either high energy (MVCT) or cone beam computed tomography (CBCT)).~Delineation of the tumor volume and evaluation of its evolution. In case of change of volume and if medically relevant, new dosimetric scan and collection of the tumor volume."

OTHER

Pre-radiotherapy mpMRI

"Performed less than 14 days before the dosimetric scan. Conventional morphological T1-weighted, T2-weighted, and T1-weighted imaging sequences after injection of contrast agent.~Quantitative imaging sequences including multiple b-value diffusion imaging. Chemical shift sensitized sequences."

OTHER

Post-radiotherapy mpMRI

"Performed 4 to 6 weeks after the end of the radiotherapy. Conventional morphological T1-weighted, T2-weighted, and T1-weighted imaging sequences after injection of contrast agent.~Quantitative imaging sequences including multiple b-value diffusion imaging. Chemical shift sensitized sequences."

PROCEDURE

Tumor resection

Performed 6 to 8 weeks after the end of radiotherapy. An anatomopathological observation of the surgical specimen will be performed.

Trial Locations (1)

69373

RECRUITING

Centre Léon Bérard, Lyon

All Listed Sponsors
lead

Centre Leon Berard

OTHER